No. SB 222
Filed under Insurance.
Cost-sharing Requirements for Diabetes Management; Prohibiting health insurance policies from imposing a cost-sharing requirement exceeding a certain amount for a 30-day supply of insulin or any diabetes device or diabetic ketoacidosis device, etc.
Plain English Summary
AI-GENERATEDFlorida health insurance policies can no longer charge more than $35 in cost-sharing for a 30-day supply of insulin, no matter how much insulin someone needs or which type they use.
The same policies can't charge more than $100 in cost-sharing for a 30-day supply of diabetes devices, such as test strips, glucometers, lancets, or insulin syringes, or for diabetic ketoacidosis devices.
These caps apply to group, blanket, and franchise health policies, prepaid limited health service plans, discount plan organizations, and HMOs, for coverage issued, renewed, or amended on or after January 1, 2027.
AIA health insurance policy cannot make an insured pay more than $35 in deductible, coinsurance, copayment, or similar cost-sharing for a 30-day supply of insulin, regardless of dose or insulin type.
AIA health insurance policy cannot make an insured pay more than $100 in cost-sharing for a 30-day supply of covered diabetes devices, such as glucose test strips or glucometers, or diabetic ketoacidosis devices.
AIThe caps reach all Florida health insurance policies delivered, issued, renewed, or amended on or after January 1, 2027, including group, blanket, and franchise policies, prepaid limited health service organizations, discount plan organizations, and HMOs.